ask="32.00"
ask_size="1000"
average_daily_volume="271905"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+1.66"
change_from_200_day_moving_average="0.85"
change_from_50_day_moving_average="0.70"
change_from_52_week_high="-6.93"
change_From_52_week_low="16.99"
change_in_percent="+5.47%"
close="31.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="29906000"
high="32.17"
high_52_weeks="38.92"
last_trade_date="2/27/2017"
last_trade_price="31.99"
last_trade_size="16234"
last_trade_time="4:00pm"
low="30.32"
low_52_weeks="15.00"
market_capitalization="1.66B"
moving_average_200_day="31.14"
moving_average_50_day="31.29"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="30.32"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+2.73%"
percent_change_from_50_day_moving_average="+2.24%"
percent_change_from_52_week_high="-17.81%"
percent_change_from_52_week_low="+113.27%"
previous_close="30.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.90"
price_per_sales="33.63"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="280722"
weeks_range_52="15.00 - 38.92"
